Ananya Pongpaibul

Ananya Pongpaibul

Auto-generated profile, based on publicly available information

Ananya Pongpaibul

Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Cancer
Verified
Journal Article
Open access
SYSupaporn Yangngam
Supaporn Yangngam
STSuyanee Thongchot
Suyanee Thongchot
APAnanya Pongpaibul
Ananya Pongpaibul
KVKulthida Vaeteewoottacharn
Kulthida Vaeteewoottacharn
SPSomchai Pinlaor
Somchai Pinlaor
CTChanitra Thuwajit
Chanitra Thuwajit
Interleukin 33 (IL-33) promotes cholangiocarcinoma (CCA) genesis in a mouse model, however, its function in human CCA has not been clearly understood. This study was aimed to investigate IL-33 level in CCA tissues and its clinicopathological correlations. The results revealed that IL-33 was found in both cancer cells and stromal cancer-associated fibroblast (CAFs) staining patterns which were divided into high (CH) and low level (CL) in cancer cells; and presence (FP) and absence (FA) in CAFs. Kaplan-Meier analysis showed that patients in the CL group were significantly correlated with a short 2-year survival time (P = 0.027). The CL/FP group had a shorter survival time compared to the other groups with statistical significance for 2-year (P = 0.030) and 5-year (P = 0.023) survivals. In contrast, CH/FP patients had significantly greater 2-year (P = 0.003) and 5-year (P = 0.003) survivals. Univariate and multivariate analysis confirmed that CL/FP was a significantly independent risk factor whereas CH/FP was a significant protective factor in CCA patients. High IL-33 expressing CCA cells had low migration, but they showed increased migration when IL-33 expression was knocked down. The low level of recombinant human IL-33 (rhIL-33) (0.002 - 2 ng/ml) could promote CCA cell migration, in contrast to the suppressive effect at a high dose (20 - 200 ng/ml). In conclusion, the combination of high IL-33 level in cancer cells and CAFs is a potentially good prognosis marker in CCA patients. The in vitro migration suppressive effect of IL-33 may be the potential mechanism supporting its role as a good prognostic marker in CCA patients. The obtained results strengthen IL-33 as a promising predictor and therapeutic target for CCA.

7 September 2018 in Paediatrics and International Child Health
Verified
Journal Article
Closed access
MCMonthira Chowichian
Monthira Chowichian
PAPrapun Aanpreung
Prapun Aanpreung
APAnanya Pongpaibul
Ananya Pongpaibul
SCSirirat Charuvanij
Sirirat Charuvanij
Systemic lupus erythematosus (SLE) is a multisystem, autoimmune inflammatory disease which can affect any organ, including the gastrointestinal tract. Lupus enteritis is one of the manifestations of gastrointestinal involvement in SLE patients. However, it is exceedingly rare that lupus enteritis is the sole initial presentation of SLE. A 12-year-old Thai girl who had had recurrent abdominal pain for 2 months with no other signs of SLE on initial presentation is described. A single-balloon enteroscopy demonstrated segmental erythema of the proximal and mid-jejunum. Histopathology demonstrated active enteritis and submucosal vasculitis. On the basis of evidence of intestinal vasculitis, autoimmune profiles were performed; the results supported the possibility of SLE. She subsequently developed leucopenia, lymphopenia and an oral ulcer, leading to a robust diagnosis of SLE. Her clinical condition improved dramatically with prednisolone. Even though lupus enteritis is rare, it can be the initial presentation of SLE. In young adolescent girls with recurrent abdominal pain, the possibility of lupus enteritis should be borne in mind.

23 May 2022 in Journal of Clinical and Translational Hepatology
Verified
Journal Article
Open access
PDF file
MRManus Rugivarodom
Manus Rugivarodom
APAnanya Pongpaibul
Ananya Pongpaibul
SCSiwaporn Chainuvati
Siwaporn Chainuvati
SNSupot Nimanong
Supot Nimanong
WCWatcharasak Chotiyaputta
Watcharasak Chotiyaputta
PCPhunchai Charatcharoenwitthaya
Phunchai Charatcharoenwitthaya
Metabolic dysfunction-associated fatty liver disease (MAFLD) is prevalent in patients with chronic hepatitis B (CHB). The effect of the histologic MAFLD phenotype on long-term CHB outcomes is unknown. We performed a longitudinal study to determine the prognostic relevance of biopsy-proven hepatic steatosis and steatohepatitis for CHB patients.

30 May 2024 in IEEE Open Journal of Engineering in Medicine and Biology
Verified
Journal Article
Open access
NSNarongrid Seesawad
Narongrid Seesawad
PIPiyalitt Ittichaiwong
Piyalitt Ittichaiwong
TSThapanun Sudhawiyangkul
Thapanun Sudhawiyangkul
PSPhattarapong Sawangjai
Phattarapong Sawangjai
PTPeti Thuwajit
Peti Thuwajit
TWTheerawit Wilaiprasitporn
Theerawit Wilaiprasitporn
Background: Deep learning models for patch classification in whole-slide images (WSI) have shown promise in assisting follicular lymphoma grading. However, these models often require pathologists to identify centroblasts and manually provide refined labels for model optimization. Objective: To address this limitation, we propose PseudoCell , an object detection framework for automated centroblast detection in WSI, eliminating the need for extensive pathologist's refined labels. Methods: PseudoCell leverages a combination of pathologist-provided centroblast labels and pseudo-negative labels generated from undersampled false-positive predictions based on cell morphology features. This approach reduces the reliance on time-consuming manual annotations. Results: Our framework significantly reduces the workload for pathologists by accurately identifying and narrowing down areas of interest containing centroblasts. Depending on the confidence threshold, PseudoCell can eliminate 58.18-99.35% of irrelevant tissue areas on WSI, streamlining the diagnostic process. Conclusion: This study presents PseudoCell as a practical and efficient prescreening method for centroblast detection, eliminating the need for refined labels from pathologists. The discussion section provides detailed guidance for implementing PseudoCell in clinical practice.

23 June 2021 in Asia-Pacific Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
KKKrittiya Korphaisarn
Krittiya Korphaisarn
KSKanjana Sukhokanjanachusak
Kanjana Sukhokanjanachusak
APAnanya Pongpaibul
Ananya Pongpaibul
VCVitoon Chinswangwatanakul
Vitoon Chinswangwatanakul
CACharuwan Akewanlop
Charuwan Akewanlop

3 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
CWChalisa Wongcharoen
Chalisa Wongcharoen
SHSaowalak Hunnangkul
Saowalak Hunnangkul
APAnanya Pongpaibul
Ananya Pongpaibul
NANapat Angkathunyakul
Napat Angkathunyakul
ObjectivesColonic adenocarcinoma poses a significant global health burden. Accurate detection of serosal invasion (pT4) is crucial for prognosis, yet inconsistent grossing protocols create diagnostic challenges. We aimed to evaluate macroscopic predictors of serosal invasion, determine the minimum tumor blocks required for accurate staging, and assess pT4 frequency at Siriraj Hospital.Materials and MethodsWe performed a retrospective review of a cohort comprising 218 patients diagnosed with colonic adenocarcinoma. The assessment was conducted by gastrointestinal pathologists and a trainee, integrating clinical records, macroscopic characteristics, and histopathological evaluation according to the AJCC Cancer Staging Manual, 8th edition. Statistical analyses were executed to identify independent predictors of pT4a staging.ResultsThe pT4 prevalence was 20.2% (pT4a: 14.7%, pT4b: 5.5%). Multivariate analysis confirmed irregular serosa as a strong predictor (aOR: 7.03, 95% CI: 1.99–24.71). Notably, tumor penetration through the serosa on the cut surface exhibited the highest predictive value (aOR: 48.76, 95% CI: 9.43–252.15). Data indicated that submitting at least two blocks from the tumor-serosa interface ensured reliable staging.ConclusionsOur pT4 rates align with international benchmarks. Irregular serosa and macroscopic serosal penetration are robust pT4a predictors. We recommend meticulous gross examination and submitting a minimum of two blocks from the deepest invasion point to optimize staging accuracy.